A detailed history of Shaker Investments LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Shaker Investments LLC holds 16,186 shares of CPRX stock, worth $375,191. This represents 0.13% of its overall portfolio holdings.

Number of Shares
16,186
Previous 19,993 19.04%
Holding current value
$375,191
Previous $433,000 26.56%
% of portfolio
0.13%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

SELL
$19.13 - $22.22 $72,827 - $84,591
-3,807 Reduced 19.04%
16,186 $318,000
Q2 2025

Jul 31, 2025

BUY
$21.4 - $26.31 $201,609 - $247,866
9,421 Added 89.11%
19,993 $433,000
Q1 2025

Apr 23, 2025

BUY
$19.53 - $25.74 $206,471 - $272,123
10,572 New
10,572 $256,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.38B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Shaker Investments LLC Portfolio

Follow Shaker Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shaker Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shaker Investments LLC with notifications on news.